摘要
随着新药和新疗法的选择,前列腺癌全身治疗的方案正在迅速发展。为了更新共享的泌尿肿瘤实践的背景知识,我们回顾了目前在全身治疗中的陈述和标志。非转移性和转移性疾病的许多新药物正在研究中。同样,正在开发新的目标成像技术,以提高对真正的非转移和真正转移患者的检测率。五种新药已显示对转移性前列腺癌的无进展生存率和总体生存率有效。但是,这些治疗方法的最佳顺序需要进一步研究。新药的耐受性和副作用以及它们对疾病的活性也是至关重要的问题。泌尿肿瘤科团队必须及时了解新的医学疗法,以便有信心与参与前列腺癌决策的其他专业人员进行辩论。在多学科小组讨论中,应分享不同的观点和细微差别,以实现疾病管理中的平衡决策。
关键词: 前列腺癌,雄激素剥夺治疗,抗雄激素,前列腺癌单位,多西他赛,全身治疗。
Current Cancer Drug Targets
Title:Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective
Volume: 21 Issue: 2
关键词: 前列腺癌,雄激素剥夺治疗,抗雄激素,前列腺癌单位,多西他赛,全身治疗。
摘要: The scenario of systemic therapy for prostate cancer is rapidly evolving, with new drugs and new treatment options. To update the background knowledge of shared uro-oncologic practice, we reviewed current statements and landmarks in systemic therapy. A number of new agents are under investigation in non-metastatic and metastatic disease. Similarly, new target imaging technologies are under development to improve the detection rate of true non-metastatic and true metastatic patient. Five new drugs have shown to be effective on progression-free and overall survival in metastatìc prostate cancer. However, the optimal sequencing of these treatments requires further investigation. The tolerability and side effects of the new drugs are also crucial issues to be discussed, as well as their activity against the disease. The uro-oncologic team has to stay updated about new medical therapies in order to be confident in debating with other professionals involved in prostate cancer decision making. Different points of view and nuances should be shared during multidisciplinary group discussions to achieve a balanced decision in disease management.
Export Options
About this article
Cite this article as:
Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective, Current Cancer Drug Targets 2021; 21 (2) . https://dx.doi.org/10.2174/1568009620666201021163919
DOI https://dx.doi.org/10.2174/1568009620666201021163919 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Medicinal Chemistry of Estrogen-related Receptor Alpha
(ERRα) Inverse Agonists
Current Topics in Medicinal Chemistry A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials
Current Drug Metabolism CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets Extracts of <i>Anogeissus leiocarpus and Dillenia indica</i> Inhibit the Growth of MCF-7 Breast Cancer and COV434 Granulosa Tumor Cells by Inducing Apoptosis and Autophagy
Current Bioactive Compounds Phosphoproteomics as a Promising Tool for Broadening the Analysis of Clinical Samples and for the Fight Against Cancer Disease
Current Pharmaceutical Analysis Vascular Endothelial Growth Factor Receptor 1, a Therapeutic Target in Cancer, Inflammation and Other Disorders
Current Medicinal Chemistry Recent Trends in Carbon Nanotubes Based Prostate Cancer Therapy: A Biomedical Hybrid for Diagnosis and Treatment
Current Drug Delivery An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Current Pharmaceutical Design Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Current Medicinal Chemistry Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition Genotoxicity and Anticancer Effects of the Aminothiophene Derivatives SB-44, SB- 83, and SB-200 in Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design HGF and RhoGTPases in Cancer Cell Motility
Current Signal Transduction Therapy Genetic Insights into Sepsis: What have we Learned and How will it Help?
Current Pharmaceutical Design Doxycycline as Potential Anti-cancer Agent
Anti-Cancer Agents in Medicinal Chemistry Control of Copper Status for Cancer Therapy
Current Cancer Drug Targets Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type II Diabetes and Cancer
Current Medicinal Chemistry Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry Research/Review: Insights into the Mutation-Induced Dysfunction of Arachidonic Acid Metabolism from Modeling of Human CYP2J2
Current Drug Metabolism Neuro-toxic and Reproductive Effects of BPA
Current Neuropharmacology